Related Experiment Video
Updated: Mar 3, 2026
07:45
Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
Published on: December 30, 2025
544
Screening for retinopathy of prematurity
L Andruscavage1, D J Weissgold
1Department of Pediatrics, College of Medicine, University of Vermont, Burlington, VT, USA.
The British Journal of Ophthalmology
|September 18, 2002
Summary
Restrictive screening criteria for retinopathy of prematurity (ROP) may lead to missed diagnoses in premature infants. Current methods might not identify all infants needing ophthalmoscopic examination for ROP.
Area of Science:
- Ophthalmology
- Neonatology
- Public Health
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Early detection through ophthalmoscopic screening is crucial for timely intervention and prevention of vision loss.
Observation:
- A cross-sectional study evaluated screening criteria for ROP in 438 premature infants over six years.
- Infants with birth weights <=1500g had a 91.7% screening rate, while those between 1501-2500g had a 52.3% rate.
- ROP, including sight-threatening stage 3, was detected in infants with larger birth weights, indicating potential under-screening.
Findings:
- Commonly used criteria for ROP screening may be too restrictive.
- A notable percentage of infants, particularly those with birth weights between 1501-2500g, were not screened despite developing ROP.
- Two infants with larger birth weights progressed to threshold ROP requiring treatment, highlighting the risk of missed diagnoses.
Implications:
- Current ROP screening guidelines may need revision to include a broader range of premature infants.
- Optimizing screening criteria can improve early detection rates and reduce the incidence of severe visual impairment due to ROP.
- Further research is warranted to refine eligibility criteria for ROP screening to ensure comprehensive care for all at-risk premature infants.
